Lithium
Lithobid, Eskalith
Also known as: Norvasc
Dihydropyridine calcium channel blocker. Lowers blood pressure, additive with ibogaine's hypotensive effect. Not a QT-prolonging agent.
Severity
Moderate caution
Mechanism
Cardiac conduction (bradycardia / AV node)
Protocol Status
Continue as prescribed — cleared by a measured lab value, not a waiting period
Restart Delay
Physician discretion
What "Moderate caution" Means
Use with caution. Often requires a brief hold, dose reduction, or enhanced monitoring rather than full discontinuation.
Clinical Action
Continue as prescribed; do not stop antihypertensive therapy on our initiative. Monitor blood pressure through the acute phase.
Where the Washout Happens
Continue as prescribed — cleared by a measured lab value, not a waiting period
This medication is not stopped for treatment, and should not be stopped on our initiative — the condition it treats usually outranks the interaction. What it changes is monitoring: serum potassium and magnesium are measured before the flood dose and corrected to target, and the dose is deferred until those numbers are right rather than until a number of days have passed. Any change to the prescription belongs to the prescribing physician.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
Ibogaine slows the sinus node and AV conduction. Beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and lithium can deepen bradycardia or generate higher-degree AV block. Heart-rate-slowing medications are typically held on dosing day with continuous telemetry monitoring.
Same Mechanism
Same Severity Tier
Common Questions
Moderate caution. Dihydropyridine calcium channel blocker. Lowers blood pressure, additive with ibogaine's hypotensive effect. Not a QT-prolonging agent. Continue as prescribed; do not stop antihypertensive therapy on our initiative. Monitor blood pressure through the acute phase.
Continue as prescribed — cleared by a measured lab value, not a waiting period. This medication is not stopped for treatment, and should not be stopped on our initiative — the condition it treats usually outranks the interaction. What it changes is monitoring: serum potassium and magnesium are measured before the flood dose and corrected to target, and the dose is deferred until those numbers are right rather than until a number of days have passed. Any change to the prescription belongs to the prescribing physician.
Cardiac conduction (bradycardia / AV node). Ibogaine slows the sinus node and AV conduction. Beta-blockers, non-dihydropyridine calcium channel blockers, digoxin, and lithium can deepen bradycardia or generate higher-degree AV block. Heart-rate-slowing medications are typically held on dosing day with continuous telemetry monitoring.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Amlodipine — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 145 medications in the A–Z directory.